Phil: Funding, Investors & Team (Sep 2026)
Phil provides a technology-based platform that makes it easier for retail and specialty-lite brands to access medications. The goal of their solutions is to enhance patient results and boost business success by making the process of prescribing medication more efficient. PhilRx includes features like a digital center, improved prior authorization, a connected pharmacy network, and comprehensive visibility and data analysis.
Phil has raised $116M across 2 funding rounds on record, the most recent an undisclosed round of $60.0M announced in Jul 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Phil Company Profile and Key Stats
Latest funding round on record: Jul 2025.
Phil Funding Rounds
Phil raised $56.0M in an undisclosed round announced in Jun 2021.
4.1 years later, an undisclosed round of $60.0M was announced in Jul 2025.
Phil Founders and Leadership Team
Contact details for the Phil team: 1 of 2 have an email address on file.
Start 14-day free trial →Phil Funding Compared to Other Biotechnology Startups
Phil's latest round of $60.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Phil in Biotechnology and Scottsdale
Companies Similar to Phil
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Shennon Biotechnologies conducts a thorough examination and control of an enormous quantity of cells,…
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
Phil Funding FAQs
What does Phil do?
Phil provides a technology-based platform that makes it easier for retail and specialty-lite brands to access medications. The goal of their solutions is to enhance patient results and boost business success by making the process of prescribing medication more efficient. PhilRx includes features like a digital center, improved prior authorization, a connected pharmacy network, and comprehensive visibility and data analysis.
How much funding has Phil raised?
Phil has raised $116M across 2 rounds on record. The most recent is an undisclosed round of $60.0M announced in Jul 2025.
When did Phil last raise funding?
Phil's most recent funding round on record is an undisclosed round of $60.0M, announced in Jul 2025.
Who founded Phil?
FundedIQ lists Puran Singh (Founder) at Phil.
Who is the CEO of Phil?
Deepak Thomas is listed as CEO at Phil.
Where is Phil headquartered?
Phil is based in Scottsdale, Arizona, United States.
How many employees does Phil have?
Phil is in the 251-500 employee band.
How does Phil's funding compare to other Biotechnology startups?
Phil's latest round of $60.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Phil Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Phil is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.